Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Ventas, Welltower See Growth Amid Senior Housing Push No Photo Available

Charlie Innis

Real estate investment trusts Welltower Inc. and Ventas Inc. recorded strong financial results from the last quarter and the full year... (more story)

This Week's Healthcare Earnings: Lilly, Cigna And More No Photo Available

Yeji Jesse Lee

About a dozen major healthcare companies have posted year-end results and issued 2026 guidance in recent days, including major names l... (more story)

Meet The Attys For Novo Nordisk In Hims & Hers GLP-1 Row No Photo Available

Gianna Ferrarin

Rodger D. Smith II and Jeremy A. Tigan of Morris Nichols Arsht & Tunnell LLP represent Novo Nordisk in its challenge against telehealt... (more story)